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Concise synthetic routes to 2H-benzo[b]thieno[3,2-b][1,5]oxazocin-6(3H)-one, and the
new

benzo[b]thieno[3,2-b][1,5]oxazonin-7(2H)-one

and

2H-benzo[b]thieno[3,2-

b][1,5]oxazecin-8(3H)-one systems, have been developed based on intramolecular
nucleophilic displacement in the key ring forming step.

Introduction
Although much progress has been made in the synthesis of N,O-containing fused medium
ring systems, many opportunities for new systems remain.[1] Such compounds are of
inherent chemical interest and are also of significance as novel scaffolds for
pharmaceutical development,[2-4] particularly 8-membered systems.[5-9]
As part of some structure-pharmacological activity studies on benzo[b]thiophene-based
potentiators of the action of serotonin, we required systems in which amide functionality
at the 2-position of the benzo[b]thiophene was incorporated in a semi-flexible ring
system, while retaining an electronegative group at the 3-position. Fused medium sized
[1,5]-oxaza systems 1 (Scheme 1) were thus considered as synthetic targets.
--------------------* Present address: Avipep Pty Ltd, 343 Royal Parade, Parkville, Vic., 3052, Australia

N-Substituted 3-hydroxy derivatives of the fused eight-membered ring system 1a are
known (although not the parent lactam 1a itself), and were made by lactamisation in the
final medium ring forming step.[10] Lactam formation also featured in approaches to the
recently described 10-methoxy and 10-benzyloxy derivatives of 1a which had some
inhibitory activity against protein kinase D, an enzyme involved in a number of important
cellular processes.[11] The fused nine- and ten-membered ring systems 1b and 1c
respectively have not been described previously, although representatives with isomeric
[1,4]- and [1,5]-oxaza fused skeletons have been reported.[12] It is of interest to note that
the fused 7-membered ring analogue (1, n=1) and bio-active derivatives (cell adhesion
and HIV inhibitors) have been reported and were accessed by lactamisation at the final
step.[13,14]
Our new ring construction approach to the systems of type (1a-c) involved an
alternative and versatile O-CH2 bond formation by nucleophilic displacement at saturated
carbon in the final cyclisation step. The results of this work are presented in this paper.
Results and Discussion
The essential precursors for the ultimate cyclisation reaction were the bromo amides
7a-c , which could be accessed via the alcohols 6b, 6e and 6f in a series of steps from the
readily available acid chloride 2, prepared in turn from the reaction of cinnamic acid
with thionyl chloride in the presence of pyridine[15] (Scheme 1). Substitution of the 3chloro group in acid chlorides of type 2 is readily achieved by a nucleophilic
addition/elimination sequence.[16] Thus reaction of 2 with sodium methoxide gave the 3methoxy substituted methyl ester 3,[17] from which the corresponding acid 4

[17]

could be

obtained by standard alkaline hydrolysis. Amide derivatisation was then achieved via
dicyclohexylcarbodiimide-mediated reaction of methyl β-alinate 5 (Y=COOCH3, n = 2)
with the acid 4 in the case of 6a, and with the commercially available acetal 5
(Y=CH(OCH2CH3)2, n=3) or the alcohol 5 (Y=CH2OH, n= 4), to afford 6c and 6f
respectively. These transformations proceeded in good yield and structural assignments
followed from the spectral data and methods of preparation.

With the procedure for the n=2 series further terminal functional group manipulation
via hydride reduction of 6a to the primary alcohol 6b was necessary, while in the n=3
series, the acetal intermediate 6c was hydrolysed to the aldehyde 6d and then reduced to
the required alcohol precursor 6e. In the case of 6a an uncommon reduction of the ester
functionality with sodium borohydride was involved leaving the amide group intact.
There is some precedent for such reductions (see for example [18,19]) and in this case there
may be some increased susceptibility of the ester carbonyl group to hydride attack as a
result of intramolecular H-bonding the amide N-H group. Reaction of the alcohols 6b, 6e
and 6f with boron tribromide resulted in O-demethylation with a concomitant primary
alcohol to bromide transformation to give the respective bromides 7a-c in good yields.
The key intramolecular nucleophilic displacement reaction to realise the fused medium
ring derivatives 1a-c then proceeded smoothly on treatment of 7a-c in each case with
sodium hydride in THF to generate the active 3-oxide nucleophile followed by bromide
ion loss. Structural confirmations of the annulated eight- to ten-membered ring products
rested on high resolution mass spectral data and the 1H- and 13C-NMR spectra. In the 13C
NMR the presence of the lactam carbonyl group was consistent with signals in the region
of δ166-178. Stereochemically stable rotational isomers in the medium ring products are
possible by analogy with the related bioisosteric naphthalene-ring fused oxaza systems [79]

, and some tentative evidence was seen for these in 1a-c on the basis of the NMR

spectra.
Although somewhat more severe conditions were required to form the eight- and tenmembered fused lactams compared with the nine-membered congener, yields were still
good. In all cases, delocalization of the negative charge on the 3-oxide through the 2,3benzo[b]thiophene bond to the amide carbonyl group would presumably weaken the C=N
resonance contribution to the amide and allow for rotation to the cisoid amide form.
Suitable positioning of the CH2-Br moiety would thus be realised for a subsequent
favourable exo-tet intramolecular nucleophilic displacement process. In no case was
evidence seen for competing macro ring formation (16-, 18- and 20-membered rings)
through dimerisation, nor for any smaller ring products which could result from amide
anion formation; the preferential formation of the oxide anion would be expected based
on the likely greater acidity of the 3-OH group. An analogous ring formation strategy, but

involving chloride ion displacement by a phenoxide ion, was employed to access the
benz-fused eight-membered ring derivative, 8-chloro-4,5-dihydro-2H-1,5-benzoxazocin6(3H)-one.[20]
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Scheme 1. Synthesis of the fused medium ring derivatives 1a - 1c.
Conclusion
A concise and efficient route based on O-CH2 bond formation in the final ring forming
step allowed smooth access to benzo[b]thiophene-fused [1,5]-N,O containing medium
ring systems. Extension of this methodology to prepare a range of heteroaromatic and
aromatic ring fused, medium-sized oxaza heterocyclic systems should be feasible.

Experimental
Methods and Materials
All melting points (uncorrected) were determined on a Reichert hot stage apparatus.
Infrared spectra (IR) were recorded on a Bio Rad Fourier Transform Infrared
Spectrometer FTS-7 as mulls in nujol unless otherwise stated and the absorption bands
are described as strong (s), medium (m) or weak (w).
1

H and 13C NMR spectra were determined at 399.9 MHz and 100.1 MHz, respectively,

with a Varian Unity-400 spectrometer. All the spectra were measured in CDC13 unless
otherwise stated. Mass spectra (MS) were obtained using Vacuum General 12-12,
Vacuum General Quattro and MAT-44 spectrometers by the direct insertion technique
with an electron beam energy of 70 eV and a source temperature of 200°C. The peak
intensities, in parentheses, are expressed as the percentage abundance. High resolution
MS were run by Dr X. Song of the School of Chemistry, University of Sydney or Dr N.
Davies, Central Science Laboratory, University of Tasmania. Elemental microanalyses
of samples were performed by the Queensland Microanalytical Service, Department of
Chemistry, University of Queensland. Analytical t.l.c. was performed on Merck silica
gel F254 silica on aluminium sheets. Column chromatography was performed under
medium pressure using Merck silica gel unless otherwise indicated. All solvent ratios are
v/v.
All extracts were dried over anhydrous sodium sulfate prior to being evaporated under
reduced pressure. THF was freshly distilled from sodium wire in the presence of
benzophenone under nitrogen. Other commercial chemicals and reagents were used as
received.
Synthesis
3-Chloro-benzo[b]thiophene-2-carbonyl chloride 2
Thionyl chloride (11.1 mL, 90 mmol) was added to a solution of (E)-cinnamic acid (4.5
g, 30 mmol) in toluene (50 mL) containing pyridine (0.5 mL, 3 mmol), and, after
addition, the mixture was heated at reflux for 60 h. The reaction mixture was filtered and
the filtrate was concentrated under vacuum. The residue was chromatographed on a short

column (2% ethyl acetate/hexane) to give a crude product, which was recrystallized from
CH2Cl2 to afford the acid chloride 2 (4.5 g, 64%) as yellow needles, mp 114-116 °C
(Lit.[15] mp 114-116 °C).
Methyl 3-methoxy-benzo[b]thiophene-2-carboxylate 3
Methanol (0.9 ml, 22.2 mmol) was added dropwise to a suspension of sodium hydride
(860 mg, 60% content, 21.5 mmol) in THF (15 mL) at room temperature under nitrogen.
After stirring for 1 h, a solution of the acid chloride 2 (1.7 g, 7.4 mmol) in THF (15 ml)
was added dropwise. The reaction mixture was heated at reflux overnight and then
allowed to cool to room temperature before being quenched with a saturated NH4Cl
solution. The mixture was extracted with ethyl acetate (3 x 30 mL). The combined
extracts were washed with brine (20 mL), and dried. Removal of the solvent afforded the
ester 3 (1.46 g, 89%) as colourless crystals, mp 110-112 °C (Lit.[17] mp 64.5-65.5 °C).
ν max/cm-1 1718 (s, C=O), 1593 (m). δH 8.08 (m,1H), 7.92 (m, 1H), 7.60 (m, 2H), 4.10 (s,
3H), 3.9 (s, 3H). m/z (EI+) 222 (100%, M+·), 207 (10), 191 (60), 176 (45).
3-Methoxy-benzo[b]thiophene-2-carboxylic acid 4
A mixture of the ester 3 (1 g, 4.5 mmol) and sodium hydroxide (1 M, 5 mL) in
methanol (25 mL) was stirred overnight. The solvent was removed and the residue
dissolved in water (5 mL) and neutralized with hydrochloric acid (1 M) to give a
precipitate. Filtration under vacuum afforded the acid 4 (0.9 g, 97%) as colourless
crystals, mp 250 °C (dec.) (Lit.[17] mp 176-177 °C). ν max/cm-1 1686 (m, C=O).
δH 8.08 (m, 1H), 7.92 (m, 1H), 7.60 (m, 2H), 4.10 (s, 3H). m/z (EI+) 208 (M+•, 97), 164
(15), 149 (40).
N-(3-Methoxy-benzo[b]thien-2-oyl)-β-alanine methyl ester 6a
A solution of β-alanine methyl ester (5, Y=COOCH3, n=2; 150 mg, 1.4 mmol) in DMF
(? mL) was added to a solution of the acid 4 (208 mg, 1 mmol), 1,3dicyclohexylcarbodiimide (206 mg, 1 mmol) and 1-hydroxybenzotriazole (150 mg, 1.1
mmol) in DMF (10 mL). The reaction mixture was stirred overnight. The solvent was
removed under vacuum and the residue was column chromatographed (20%, then 40%

ethyl acetate/hexane) to give the ester 6a (230 mg, 79%) as colourless crystals, m.p. 6162 °C. ν max/cm-1 (film) 3387 (m, NH), 1732 (s, COOCH3), 1641 (s, ArCONH), 1535 (s).
δH 8.10 (br.s, 1H), 7.82-7.80 (m, 2H), 7.43-7.39 (m, 2H), 4.10 (s, 3H), 3.75(dt, J 6.0, 6.8,
2H), 3.72 (s, 3H), 2.68 (t, J 6.0, 2H). δC 172.9, 161.6, 150.5, 137.8, 132.4, 126.6, 124.3,
123.6, 123.5, 122.0, 61.9, 51.7, 48.8, 34.8. m/z (ESI+) 316 (M+Na+, 100), 294 (MH+,
10). m/z (HRMS; EI+) M+•. Calc. for C14H15NO4S: 293.0722, found 293.0728.
N-(3'-Hydroxypropyl)-3-methoxy-benzo[b]thiophene-2-carboxamide 6b
An excess of sodium borohydride (20 mg, 0.8 mmol) was added to a solution of the
methyl ester 6a (140 mg, 0.48 mmol) in ethanol (5 ml) and the mixture was stirred
overnight. A saturated ammonium chloride solution was added and the aqueous mixture
was extracted with ethyl acetate (3x10 ml). The extract was washed with brine (10 ml),
dried and evaporated to afford a crude product, which was chromatographed (60% ethyl
acetate/hexane) to yield the alcohol 6b (125 mg, 98%) as colourless crystals, mp 6466°C. ν

-1
max/cm

(film) 3379 (s, broad, OH, NH), 3060 (w), 2878 (w). 1626 (s, C=O),

1542 (s) cm-1. δH 7.84-7.80 (m, 3H), 7.46-7.41(m, 2H), 4.13 (s, 3H), 3.74 (t, J 5.6, 2H),
3.67 (dt, J1 6.4, J2 6.0, 2H), 1.85-1.82 (m, 2H). δC 162.8, 150.7, 137.8, 132.3, 126.7,
124.4, 123.5, 122.9, 122.0, 61.9, 59.5, 36.5, 32.1. m/z (ESI+) 266 (MH+, 100). m/z
(HRMS; EI+) M+•. Calc. for C13H15NO3S: 265.0773, found 265.0776.
N-(3'-Bromopropyl)-3-hydroxy-benzo[b]thiophene-2-carboxamide 7a
An excess of boron tribromide (0.25 mL) was added dropwise to a solution of the
alcohol 6b (100 mg, 0.38 mmol) in CH2Cl2 (5 mL) at -78°C under nitrogen. The dry-ice
bath was then removed and the reaction mixture stirred overnight. The reaction was
quenched with water and the reaction mixture extracted with CH2Cl2 (3 x15 mL). The
combined extracts were washed with brine (10 mL), dried and evaporated. Column
chromatography of the residue (60% ethyl acetate/hexane) afforded the bromo derivative
7a (80 mg, 69%) as a white powder, mp 135-136 °C. ν max/cm-1 3349 (w, NH), 1611 (m,
C=O). δH 7.94 (d, J 8.0, 1H), 7.71 (d, J 8.0, 1H), 7.48 (dt, J1 1.2 , J2 8.0, 1H), 7.42 (dt, J1
1.2, J2 8.0, 1H), 5.78 (br.s, 1H), 3.63 (dt, J1 6.4, J2 6.4 , 2H, NHCH2), 3.50 (t, J 6.4, 2H),
2.21 (quintuplet, J 6.4, 2H). δC 167.1, 158.9, 136.2, 131.2, 128.5, 124.7, 123.0, 122.9,

102.1, 38.2, 32.1, 30.7. m/z (EI+) 315, 313 (M+•, 10), 297, 295 (5). m/z (HRMS; EI+)
M+•. Calc. for C12H1279BrNO2S: 312.9772, found 312.9771.
4,5-Dihydro-2H-benzo[b]thieno[3,2-b][1,5]oxazocin-6(3H)-one 1a
Sodium hydride (10 mg, 0.4 mmol) was added to a solution of the bromide 7a (30 mg,
0.1 mmol) in THF (10 ml) under nitrogen. After stirring for 2 h, no reaction was observed
by t.l.c. analysis (20% ethyl acetate/hexane). The reaction mixture was then heated at
reflux for 2h and quenched with water. The mixture was extracted with ethyl acetate
(3x15 ml) and the combined extracts were washed with brine (10 mL), and dried. The
solvent was evaporated to furnish a crude product, which was subjected to column
chromatography (methanol: ethyl acetate:hexane 10:80:100) to give the cyclized
compound 1a (15 mg, 68%) as a yellow powder, mp 196-197°C. ν

-1
max/cm

1626 (s,

C=O). δH 7.98-7.94 (m, 1H), 7.62-7.59 (m, 1H), 7.42 (dt, J1 1.2, J2 8.0, 1H), 7.28 (dt, J1
1.2, J2 8.0, 1H), 4.49-4.40 (m, 2H), 3.60-3.56 (m, 2H), 2.22-2.16 (m, 2H). δC 178.5,
162.8, 140.6, 134.7, 129.6, 124.2, 123.5, 123.3, 90.0, 66.3, 37.5, 21.2. m/z (EI+) 233
(M+•, 55). m/z (HRMS; EI+) M+• . Calc. for C12Hl1NO2S: 233.0511, found 233.0479.
Anal. Calc. for C12H11NO2S.H2O: C 57.36, H 5.21, N 5.57. Found: C 57.59, H 4.66, N
5.67 %.

N-(3 '-Methoxy-benzo[b]thien-2'-oy1)-4-aminobutanal 6d
A mixture of the acid 4 (208 mg, 1 mmol), 1,3-dicyclohexylcarbodiimide (206 mg, 1
mmol), 1-hydroxybenzotriazole (150 mg, 1.1 mmol) and 4-aminobutanal diethyl acetal 5
(Y=CH(OCH2CH3)2, n=3; 0.3 ml, 1.74 mmol) in THF (15 mL) was stirred overnight. The
reaction was quenched with water and the aqueous mixture extracted with ethyl acetate
(3x15 mL). The combined extracts were washed with brine and dried. Removal of the
solvent gave a residue, which was chromatographed (20% ethyl acetate/hexane) to give
the partially characterised acetal intermediate 6c (300 mg, 85%) as colourless crystals,
mp 110-111°C. ν max/cm-1 3387 (m, NH), 3065 (w), 1648 (s), 1534. δH 7.80-7.78 (m, 2H),
7.54(br.s, 1H), 7.43-7.40 (m, 2H), 4.53 (t, J 4.8 Hz, 1H), 4.10 (s, 3H), 3.65 (q, J 7.2, 4H),

3.55-3.48 (m, 4H), 1.74-1.72 (m, 2H), 1.21 (t, J 7.2, 6H). m/z (EI) 322 (M+• - Et, <1),
305 (3), 259 (20), 224 (30), 191(100), 176 (60). m/z (HRMS; EI+) M+•. 351.1489.
C18H25NO4S requires 351.1504. The acetal 6c (70 mg, 0.2 mmol) in acetone (10 ml) was
then treated with a few drops of 1M hydrochloric acid at room temperature and stirred
overnight. The solvent was removed and the residue was chromatographed (40% ethyl
acetate/hexane) to give the aldehyde 6d (55 mg, 100%) as an oil. ν max/cm-1 3387 (s, NH),
3060 (w), 1725 (s, CHO), 1641 (s, ArCONH), 1527 (s). δH 9.80 (t, J 0.8 , 1H), 7.82-7.80
(m, 2H), 7.60 (br.s, 1H), 7.43-7.40 (m, 2H), 4.10 (s, 3H), 3.50 (dt, J1 7.2 , J2 6.8, 2H),
2.60 (t, J 6.8, 2H), 2.02 (t, J 6.8, 2H), 1.98 (t, J 6.8, 2H). δC 201.6, 162.1, 150.4, 137.9,
132.4, 126.7, 124.5, 123.7, 122.1, 108.3, 61.97, 41.4, 38.9, 29.7. m/z (EI) 277 (M+•, 8),
249 (5), 191 (100). m/z (HRMS, EI+) M+• 277.0769. C14H15NO3S requires 277.0773.

N-(4'-Hydroxybuty1)-3-methoxy-benzo[b]thiophene)-2-carboxamide 6e
An excess of sodium borohydride (20 mg, 0.8 mmol) was added to a solution of the
aldehyde 6d (55 mg, 0.2 mmol) in ethanol (10 mL) and the mixture was allowed to stir
overnight. The reaction was quenched with a saturated NH4Cl solution and the mixture
extracted with ethyl acetate (3x10 mL). The combined extracts were washed with brine
(10 mL) and dried. Removal of the solvent gave the alcohol 6e (55 mg, 100%) as
colourless crystals, mp 139-140°C. ν max/cm-1 (film) 3243 (s, broad, OH), 1641 (s, C=O),
1535 (s). δH 7.82 (dd, J1 2, J2 6.8, 2H), 7.59 (br.s, 1H), 7.42-7.40 (m, 2H), 4.10, (s, 3H),
3.74 (t, J 6.0, 2H), 3.55 (dt, J1 6.8, J2 6.4, 2H), 1.73-1.70 (m, 4H). δC 162.0, 151.0, 139.1,
132.5, 126.7, 124.5, 124.0, 123.7, 122.0, 62.3, 61.9, 39.0, 30.1, 26.50. m/z (ESI+) 280
(MH+, 100), 191 (10). m/z (HRMS; EI+) M+• 279.0929. C14H17NO3S requires 279.0929.
N-(4'-Bromobuty1)-3-hydroxy-benzo[b]thiophene-2-carboxamide 7b
Boron tribromide (0.2 ml) was added dropwise to a solution of the alcohol 6e (100 mg,
0.36 mmol) in CH2Cl2 (10 mL) at -78°C under nitrogen . The dry ice bath was then
removed and the reaction mixture stirred overnight. The reaction was quenched with
water and the mixture extracted with CH2Cl2 (3x10 mL). The combined extracts were

washed with brine (10 mL) and dried. Chromatography of the residue (10% ethyl
acetate/hexane) afforded the bromide 7b (105 mg, 90%) as a grey powder, mp 87-88°C.
ν

-1
max/cm

3354 (w, NH), 1626 (m, C=O), 1586 (s). δH 7.94 (dd, J1 0.8 , J2 8.0 , 1H),

7.72 (dd, J1 0.8 , J2 8.0, 1H), 7.49 (dt, J1 1.2 , J2 8.0 , 1H), 7.42 (dt, J1 1.2 , J2 8.0 , 1H),
5.60 (br.s, 1H), 3.5 (dt, J1 7.2 , J2 6.8 , 2H), 3.47 (t, J 6.4, 2H), 1.99-1.95 (m, 2H), 1.851.81 (m, 2H). δC 166.9, 158.9, 136.1, 131.2, 128.5, 124.7, 122.9, 122.8, 102.5, 38.6,
33.1, 29.8, 28.3. m/z (EI+) 327, 329 (M+•, 15). m/z (HRMS; EI+) M+• 326.9926.
C13H1479BrNO2S requires 326.9929.
3,4,5,6-Tetrahydro-benzo[b]thieno[3,2-b][1,5]oxazonin-7(2H)-one 1b
Sodium hydride (10 mg, 0.4 mmol) was added to a solution of the bromide 7b (40 mg,
0.12 mmol) in THF (20 mL) under nitrogen. After stirring overnight, water was added to
stop the reaction. The reaction mixture was extracted with ethyl acetate (3x15 mL). The
extracts were washed with brine (10 mL), and dried. The solvent was evaporated to
furnish, after column chromatography (15% ethyl acetate/hexane) of the residue, the
cyclized compound 1b (28 mg, 70%) as colourless crystals, mp 95-96°C. ν max/cm-1 1621
(w, C=O), 1565 (s). δH 7.99-7.96 (m, 1H), 7.75-7.73 (m, 1H), 7.48 (dt, J1 1.2 , J2 8.0,
1H), 7.41 (dt, J1 1.2, J2 8.0, 1H), 3.84-3.80 (m, 4H), 2.01-1.98 (m, 4H). δC 166.6, 160.9,
137.9, 130.8, 128.1, 124.3, 122.8, 122.4, 101.6, 76.6, 47.0 (C3,4,5). m/z (EI+) 247 (M+•,
69). m/z (HRMS; EI+) M+• 247.0670. C13H13NO2S requires 247.0667. Anal. Calc. for
C13H13NO2S: C 63.14, H 5.30, N 5.66. Found: C 63.55, H 5.80, N 5.19 %.
N-(5'-Hydroxypenty1)-3-methoxy-benzo[b]thiophene-2-carboxamide 6f
A mixture of the acid 4 (208 mg, 1 mmol), 1,3-dicyclohexylcarbodiimide (206 mg, 1
mmol), 1-hydroxybenzotriazole (150 mg, 1.1 mmol) and 5-aminopentan-l-ol in DMF (10
mL) was stirred overnight. The solvent was removed under high vacuum, and the residue
was chromatographed (30% ethyl acetate/hexane) to afford the alcohol 6f (240 mg, 80%)
as colourless crystals, mp 68-69°C. ν max/cm-1 (film) 3463 (m, OH), 3387 (m, NH), 1634
(s, C=O), 1535 (s). δH 7.83-7.80 (m, 2H), 7.53 (br.s, 1H), 7.42-7.39 (m, 2H), 4.1 (s, 3H),
3.67 (t, J 6.4, 2H), 3.50 (dt, J1 7.2, J2 6.8, 2H), 1.76 (br.s, 1H), 1.66-1.68 (m, 4H), 1.521.49 (m, 2H). δC 161.8, 150.0, 137.7, 132.4, 126.6, 124.4, 123.6, 121.9, 124.2, 62.5,

61.9, 39.3, 32.3, 29.6, 23.1. m/z (ESI-) 292 (M-1, 65); (ESI+) 316 (MNa+, 100), 294
(MH+, 22). m/z (HRMS; EI+) M+• 293.1090. C15H19NO3S requires 293.1086.
N-(5'-Bromopenty1)-3-hydroxy-benzo[b]thiophene-2-carboxamide 7c
An excess of boron tribromide (0.2 mL) was added dropwise to a solution of the alcohol
6f (100 mg, 0.34 mmol) in CH2Cl2 (10 mL) at -78°C under nitrogen. After addition, the
dry ice bath was removed and the reaction mixture stirred overnight. The reaction was
quenched with water and the mixture was extracted with CH2Cl2 (3x10 mL). The
combined extracts were washed with brine (10 mL) and dried. Chromatography of the
residue (15% ethyl acetate/hexane) yielded the bromide 7c (100 mg, 86%) as pink
crystals, mp 94-95°C. ν max/cm-1 3356 (m, NH), 1610 (s, C=O), 1550 (m). δH 7.93 (dd, J1
0.8, J2 8.0, 1H), 7.71 (dd, J1 0.8, J2 8.0, 1H), 7.48 (dt, J1 1.2, J2 8.0, 1H), 7.40 (dt, J1 1.2,
J2 8.0, 1H), 5.60 (br.s, 1H), 3.46 (dt, J1 7.2, J2 6.8, 2H), 3.42 (t, J 6.4, 2H), 1.95-1.49 (m,
6H). δC 166.9, 158.7, 136.1, 131.2, 128.4, 124.6, 122.9, 122.8, 102.4, 39.3, 33.5, 32.1,
28.9, 25.3. m/z (ESI-) 340, 342 (M-1, 95), 79,81 (89). m/z (HRMS; EI+) M+• 341.0079.
C14H1679BrNO2S requires 341.0085.
4,5,6,7-Tetrahydro-2H-benzo[b]thieno[3,2-b][1,51oxazecin-8(3H)-one 1c
An excess of sodium hydride (10 mg, 0.4 mmol) was added to a solution of the bromide
7c (68 mg, 0.2 mmol) in THF (20 mL). After stirring for 1 hour, no reaction occurred.
The reaction mixture was heated at reflux for 1 hour, then quenched with water. The
mixture was extracted with ethyl acetate (3x10 mL). The combined extracts were washed
with brine (10 mL) and dried. The solvent was evaporated and the residue was
chromatographed (15% ethyl acetate/hexane) to give the cyclized compound 1c (42 mg,
81%) as pink crystals, mp 69-70°C. ν max/cm-1 1573 (m), 1527 (m). δH 7.98-7.96 (m, 1H),
7.72-7.70 (m, 1H), 7.47-7.45 (m, 1H), 7.42-7.39 (m, 1H), 3.86-3.83 (m, 4H), 2.08 (br.s,
1H), 1.72-1.70 (m, 6H). δC 167.0, 161.8, 137.3, 130.8, 128.4, 124.4, 122.8, 122.1, 101.2,
46.1 (2C), 26.2 (2C), 24.5. m/z (EI+) 261 (M+•, 65), 176 (94). m/z (HRMS; EI+) M+•
261.0787. C14H15NO2S requires 261.0824. Anal. Calc. for C14H15NO2S : C 64.34, H
5.79, N 5.36. Found: C 64.15, H 5.97, N 5.36 %.

Supplementary Material
NMR and mass spectra are available on the Journal’s website.
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